Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Proefschrift: Betere behandeling na herseninfarct
dec 2020 | Neuro-vasculair